BDBM50272532 4-(4-(2-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl)acetyl)-3-(pyrrolidin-1-ylmethyl)piperazin-1-ylsulfonyl)-2-hydroxybenzoic acid::CHEMBL526192

SMILES OC(=O)c1ccc(cc1O)S(=O)(=O)N1CCN(C(CN2CCCC2)C1)C(=O)Cn1c2cc(Cl)ccc2oc1=O

InChI Key InChIKey=SAGFNXSRBXHXAQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50272532   

TargetKappa-type opioid receptor(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50272532(4-(4-(2-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl)ace...)
Affinity DataEC50:  7.90E+3nMAssay Description:Agonist activity at human kappa opioid receptor expressed in CHO-K1 cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed